An Observational Study of Xeloda (Capecitabine) in Participants With Metastatic or Advanced Breast Cancer

NCT01725386 · clinicaltrials.gov ↗
COMPLETED
Status
274
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche